Follow Us
© 2026 Arizent. All rights reserved.
Caroline Hroncich is a former senior editor of Employee Benefit News and Employee Benefit Adviser.
For reprint and licensing requests for this article, click here.
Advisers who treat absence as a strategic discipline, not a vendor handoff, will have a stronger story to tell and a more valuable role to play.
The health and welfare leader and 2026 Excellence in Benefits honoree is guiding the bank in navigating them all.
Bringing a procurement partner into the benefits planning process can offer greater insight and negotiation power, helping to reduce overall costs.
As GLP-1 spending climbs, employers are asking whether the drugs deliver enough value. Better data could help them measure the payoff more accurately.
The legislation calls on Congress to lower prescription drug costs, shift subsidies directly to consumers, and enforce strict price transparency.
